|
|
|
I would like to wish you all a very happy new year.
|
2020 has been very challenging. However, the IRCAD team has been working hard, and this has resulted in the coming true of several projects:
|
- an exclusive license signature of the IRCAD spin-off, Visible Patient, with Johnson & Johnson;
- The realization of the IRCAD China project, in collaboration with the South Korean group SK, the construction of which will begin in Wuxi in February 2021;
- The creation of a TV channel allowing the professional development of webinars, to compensate for some of our on-site courses;
- The construction of a new building (IRCAD 3) totally dedicated to surgical robotics (using Medtronic and CMR Surgical robotic systems) with a 300-seat auditorium equipped with the latest technologies.
- The extension of our hotel, with an extra 115 rooms in Les Haras Hotel located 50 meters away from the Institute.
We very much look forward to welcoming you to our brand-new enlarged IRCAD France Institute as soon as possible.
|
|
|
|
|
Kindest regards, Prof. Jacques Marescaux, MD, FACS, Hon FRCS, Hon JSES, Hon FASA, Hon FJSS
|
Founder and President of IRCAD WebSurg Editor-in-Chief
|
|
|
|
|
|
|
|
Instant publications
|
Comprehensive stepwise description of urological and gynecologic procedures authored by talented teams of Italian, Mexican, British, and Polish surgeons.
|
|
|
|
|
|
Online courses on WebSurg
|
|
|
|
|
|
Next IRCAD training courses
|
|
|
|
|
|
|
|
|
State of the art
|
Fulfill your learning needs and stay up to date with the latest therapeutic management modalities and advances in minimally invasive surgery.
|
|
|
|
|
|
|
WebSurg Hall of fame
|
We are waiting for your original videos featuring comprehensive and academic topics in the field of minimally invasive surgery. Please feel free to submit your videos until the end of June 2021.
|
|
|
|
|
|
|
PORSAV partnership
|
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 101015941. The material presented and views expressed here are the responsibilities of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.
|
|
|
|
|
|